{"id":"W4385410847","doi":"10.1093/oncolo/oyad207","title":"Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2− Advanced Breast Cancer: Findings From a Multicountry Survey","year":2023,"lang":"en","type":"article","venue":"The Oncologist","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"Genentech; Plexxikon; Eisai; Seagen; MacroGenics; Les Laboratories Pierre Fabre; Genomic Health; F. Hoffmann-La Roche; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Novartis Pharmaceuticals Corporation; Bayer; AstraZeneca; Eli Lilly and Company; Breast Cancer Alliance","keywords":"Medicine; Quality of life (healthcare); Breast cancer; Anxiety; Physical therapy; Diarrhea; Cancer; Internal medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003465032,0.0002218258,0.000651946,0.00007370087,0.00006767585,0.00000774061,0.0001037861,0.00009978061,0.00002468372],"category_scores_gemma":[0.0002718011,0.0001315882,0.00003992987,0.0004819773,0.0003993817,0.00008362803,0.00004954661,0.0001635839,0.000008850527],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004414781,"about_ca_system_score_gemma":0.0001935476,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01660152,"about_ca_topic_score_gemma":0.009424921,"domain_scores_codex":[0.9985117,0.0002723191,0.0003551609,0.0003209805,0.0002436458,0.0002961885],"domain_scores_gemma":[0.9979656,0.001285851,0.0002186373,0.0003292228,0.000102702,0.00009797418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007687491,0.0003014072,0.9466318,0.00004758424,0.0002192121,0.000009280184,0.0007282849,0.0002335728,0.0007504971,0.000008776453,0.0000110319,0.04337107],"study_design_scores_gemma":[0.01633238,0.0006791661,0.9820684,0.0001756591,0.00005135551,0.000001296162,0.0002110757,0.00007393637,0.0001405816,0.00007679118,0.00004866031,0.0001407451],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973521,0.0003950563,0.000007713256,0.0006206147,0.0001088023,0.0008949436,0.0004753359,0.00008767495,0.0000577492],"genre_scores_gemma":[0.9990931,0.0001427304,0.0001525057,0.0001674084,0.0000247159,0.0001244554,0.0001404287,0.00003151572,0.0001231482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04323032,"threshold_uncertainty_score":0.989947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02245585640161177,"score_gpt":0.3213516366995914,"score_spread":0.2988957802979796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}